Table 1.
Species possibilities | Human |
---|---|
ELISA range [ng/ml] LLMR-ULMR | 9–493 ng/mL [adjusted: 36.3–1970 ng/mL] |
IC50 [mean, ng/ml] | 78.34 |
Slope [mean] | 0.94 |
Intra-ELISA mean CV%, QC | 9% [5.2-15%] |
Inter-ELISA mean CV%, QC | 4.3% [1.5-9.3%] |
Analyte recovery [%], 24 h, 4°C/20°C | 91%/95% |
Analyte recovery [%], 48 h, 4°C/20°C | 114%/138% |
Sample recovery [%], freeze/thaw cycles, 3F/T cycles/4F/T cycles | 93%/91% |
Dilution recovery [%], serum [MRD = 1:4] | 96% |
Dilution recovery [%], EDTA [MRD = 1:0] | 92% |
Spiking recovery [%], serum | 101% |
Spiking recovery [%], EDTA | 99% |
Interference, biotin recovery [%] [low/high] | 98%/95% |
Interference, lipaemia recovery [%] [low/high] | 100%/97% |
Interference, haemoglobin [%] recovery [low/high] | 91%/72% |
Percentages are reported as mean.
ELISA, enzyme-linked immunosorbent assay; EDTA, ethylene diamine tetraacetic acid; FT, freeze/thaw; LLMR, lower limit of measurement range; ULMR, upper limit of measurement range; IC50, 50% inhibitory concentration; CV%, coefficient of variance %; QC, quality control samples; MRD, maximum [or minimum] recovery diluent.